Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP

Journal of Biophotonics

Volumn 3, Issue 5-6, 2010, Pages 328-335

  Latorre Esteves, Elena ^a,b   Akilov, Oleg E ^a,c   Rai, Prakash ^a   Beverley, Stephen M ^a   Hasan, Tayyaba ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Green fluorescent protein; Leishmania; Murine model; Photodynamic therapy

Indexed keywords

CLINICAL OUTCOME; CLINICAL TRANSLATION; DEVELOPED MODEL; FLUORESCENCE INTENSITIES; GREEN FLUORESCENT PROTEIN; LEISHMANIA; MURINE MODEL; PARASITIC LOADS;

FLUORESCENCE; MONITORING; PLASMONS; PROTEINS;

PHOTODYNAMIC THERAPY;

LEISHMANIA MAJOR; MURINAE;

3,7 BIS(N,N DIBUTYLAMINO)PHENOTHIAZINIUM BROMIDE; 3,7-BIS(N,N-DIBUTYLAMINO)PHENOTHIAZINIUM BROMIDE; GREEN FLUORESCENT PROTEIN; PHENOTHIAZINE DERIVATIVE; PHOTOSENSITIZING AGENT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CALIBRATION; DISEASE MODEL; DRUG EFFECT; EAR DISEASE; FEMALE; FLUORESCENCE; GENETIC TRANSFECTION; LEISHMANIA MAJOR; METABOLISM; METHODOLOGY; MOUSE; PARASITOLOGY; PHOTOCHEMOTHERAPY; REPRODUCIBILITY; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

ANIMALS; CALIBRATION; DISEASE MODELS, ANIMAL; EAR DISEASES; FEMALE; FLUORESCENCE; GREEN FLUORESCENT PROTEINS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; PHENOTHIAZINES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REPRODUCIBILITY OF RESULTS; TRANSFECTION; TREATMENT OUTCOME;

EID: 77953951793     PISSN: 1864063X     EISSN: 18640648     Source Type: Journal    
DOI: 10.1002/jbio.201000008     Document Type: Article

References (29)

1. P. Desjeux, Comp. Immunol. Microbiol. Infect. Dis. 27, 305-318 (2004).
2. WHO, The leishmaniases. Report of a WHO expert committee, in World Health Organ Tech. Rep. Ser. 1984. pp. 1-140.
3. WHO, in Wkly Epidemiol. Rec. 2002. pp. 365-370.
4. P. Repaci, Emerging health issue: Leishmaniasis among soldiers in OIF/OEF. In: C. Underwood (ed): DASG-PPM-NC 2005, pp. 1-3 (2005).
5. A. A. Alrajhi, Skin Therapy Lett. 8, 1-4 (2003).
6. A. A. Alrajhi, E. A. Ibrahim, E. B. De Vol, M. Khairat, R. M. Faris, and J. H. Maguire, N. Engl. J. Med. 346, 891-5 (2002).
7. R. Aragort de Rossell, O. Rossell, R. de Jesus de Duran, and A. M. Rodriguez, Ann. Trop. Med. Parasitol. 87, 23-30 (1993).
8. J. Alvar, S. Croft, and P. Olliaro, Adv. Parasitol. 61, 223-274 (2006).
9. B. Papadopoulou, C. Kundig, A. Singh, and M. Ouellette, Drug Resist. Updat. 1, 266-278 (1998).
10. O. E. Akilov, S. Kosaka, K. O'Riordan, and T. Hasan, Photochem. Photobiol. Sci. 6, 1067-1075 (2007).
11. O. E. Akilov, S. Kosaka, K. O'Riordan, and T. Hasan, Exp. Dermatol. 16, 651-660 (2007).
12. C. D. Enk, C. Fritsch, F. Jonas, A. Nasereddin, A. Ingber, C. L. Jaffe, and T. Ruzicka, Arch. Dermatol. 139, 432-434 (2003).
13. K. Gardlo, Z. Horska, C. D. Enk, L. Rauch, M. Megahed, T. Ruzicka, and C. Fritsch, J. Am. Acad. Dermatol. 48, 893-896 (2003).
14. N. Solban, B. Ortel, B. Pogue, and T. Hasan, Ernst Schering Res. Found Workshop 229-258 (2005).
15. K. Gardlo, S. Hanneken, T. Ruzicka, and N. J. Neumann, Hautarzt 55, 381-383 (2004).
16. A. Asilian and M. Davami, Clin. Exp. Dermatol. 31, 634-637 (2006).
17. O. E. Akilov, W. Yousaf, S. X. Lukjan, S. Verma, and T. Hasan, Laser Surg. Med. 41, 358-365 (2009).
18. O. E. Akilov, S. Kosaka, E. V. Maytin, and T. Hasan, J. Dermatol. 35, 197-205 (2008).
19. O. E. Akilov, S. Kosaka, K. O'Riordan, X. Song, M. Sherwood, T. J. Flotte, J. W. Foley, and T. Hasan, Chem. Biol. 13, 839-847 (2006).
20. D. S. Ha, J. K. Schwarz, S. J. Turco, and S. M. Beverley, Mol. Biochem. Parasitol. 77, 57-64 (1996).
21. Y. Belkaid, S. Kamhawi, G. Modi, J. Valenzuela, N. Noben-Trauth, E. Rowton, J. Ribeiro, and D. L. Sacks, J. Exp. Med. 188, 1941-1953 (1998).
22. G. F. Spath and S. M. Beverley, Exp. Parasitol. 99, 97-103 (2001).
23. G. M. Kapler, C. M. Coburn, and S. M. Beverley, Mol. Cell Biol. 10, 1084-1094 (1990).
24. R. Breitling, S. Klingner, N. Callewaert, R. Pietrucha, A. Geyer, G. Ehrlich, R. Hartung, A. Muller, R. Contreras, S. M. Beverley, and K. Alexandrov, Protein Expr. Purif. 25, 209-218 (2002).
25. N. Singh and A. Dube, Am. J. Trap. Med. Hyg. 71, 400-402 (2004).
26. N. K. Verma and C. S. Dey, Antimicrob. Agents. Chemother. 48, 3010-3015 (2004).
27. S. R. Mehta, R. Huang, M. Yang, X. Q. Zhang, B. Kolli, K. P. Chang, R. M. Hoffman, Y. Goto, R. Badaro, and R. T. Schooley, Clin. Vaccine Immunol. 15, 1764-1770 (2008).
28. T. M. Sitnik, J. A. Hampton, and B. W. Henderson, Br. J. Cancer 77, 1386-1394 (1998).
29. T. M. Sitnik and B. W. Henderson, Photochem. Photobiol. 67, 462-466 (1998).